On 3 February 2023 the Department of Justice (DOJ) announced that it is withdrawing from certain policy statements related to antitrust enforcement in healthcare. Specifically, DOJ is withdrawing “safe harbors” for...more
On 25 February the U.S. Department of Justice (DOJ) submitted a statement of interest in a Nevada State court lawsuit filed by a group of anesthesiologists alleging that non-compete provisions in their employment agreements...more
The Covid-19 pandemic has caused upheaval across labor markets and resulted in what some have termed the “Great Resignation.” In the midst of these challenging labor market conditions, employers should be aware that the U.S....more
Read the latest news on antitrust, competition and economic regulation (ACER) in this Spring's edition of our quarterly ACER newsletter.
...more
7/17/2019
/ ACPERA ,
Antitrust Provisions ,
AT&T ,
Competition ,
Department of Justice (DOJ) ,
Federal Trade Commission (FTC) ,
FinTech ,
FRAND ,
Health Care Providers ,
Hospitals ,
Leniency Programs ,
Pharmaceutical Industry ,
Public Procurement Policies ,
Regulatory Standards ,
Sherman Act ,
Total Cost of Care Model (TCOC) ,
Whistleblowers